Stanford University
Showing 671-680 of 939 Results
-
Lili Liu
Postdoctoral Scholar, Epidemiology
BioLili (Larry) Liu, PhD, is a postdoctoral fellow in the Department of Epidemiology and Population Health at Stanford University. Dr. Liu is an integrative epidemiologist whose research is unified by a consistent methodological approach rather than a single disease area. Across his master’s, doctoral, and postdoctoral training, he has repeatedly developed or operationalized epidemiologic frameworks and analytic programs and applied them to important public health questions spanning rare diseases, chronic disease, cancer, mortality, microbiome, and women’s health. His work brings together molecular biomarkers, large-scale population cohorts, and real-world health data to generate coherent, hypothesis-driven research on how genetic variation, lifestyle, pharmacologic factors, and early-life exposures shape inflammation, biological aging, and chronic disease risk across the life course.
During his master’s training at Peking University, Dr. Liu developed expertise in literature synthesis, national claims-based study, rare disease burden estimation, patient-centered health information research, cohort-based analysis, and vaccine effectiveness evaluation. He helped build and apply claims-based analytic algorithms to estimate incidence and prevalence for multiple rare diseases in China, led first-author studies on online health information and patient information needs in rare disease populations, and established an analytic framework for CHARLS-based cohort studies that supported multiple downstream projects. During his PhD training at Vanderbilt University, he expanded into population genetics, molecular and cancer epidemiology, mortality and health disparities research, gut microbiome, and pooled multi-study analyses. His doctoral work included a multi-ancestry GWAS of urinary prostaglandin E2 metabolite (PGE-M), development of PGE-M-derived dietary and lifestyle scores, and Mendelian randomization analyses linking lipid-related pathways to colorectal cancer risk. He also led several first-author studies in the Southern Community Cohort Study on poverty, sitting time, physical activity, walking and mortality, and alcohol intake and the gut microbiome, several of which received substantial public health and media attention.
At Stanford, Dr. Liu has developed an independent research program centered on women’s health and life-course epidemiology using U.S. national claims data. He has built large nationwide pregnancy and mother-baby cohorts from MarketScan to study adverse obstetric outcomes, long-term cardiometabolic and hepatic outcomes, and early-onset cancer risk. His first corresponding-author paper at Stanford examined gestational diabetes in relation to subsequent type 2 diabetes and metabolic dysfunction-associated steatotic liver disease, and his ongoing work extends this framework to cardiovascular, kidney, metabolic, and reproductive health outcomes, including PCOS and endometriosis. He also received a Stanford MCHRI fellowship grant to study prenatal and early-life antibiotic exposure in relation to pediatric inflammatory bowel disease and celiac disease. In parallel, his collaborative work includes placental and maternal-fetal research on extracellular vesicles and angiogenic signaling.
Methodologically, Dr. Liu works at the interface of causal inference, pharmacoepidemiology, molecular epidemiology, and scalable real-world data science, using reproducible analytic pipelines in R, Python, SQL, and high-performance computing environments. Across all stages of his training, the central theme of his work has been to build scalable analytic infrastructure and apply it to high-impact epidemiologic questions with broad public health relevance, with the overarching goal of translating rigorous population science into actionable strategies for chronic disease prevention in diverse populations. -
Lin Liu
Postdoctoral Scholar, Chemistry
BioI finished my undergraduate study in general chemistry at Shandong Normal University in 2014. Later, I continued to my master’s studies in organic chemistry at Lanzhou University. In 2018, I moved to Baylor University conducting research under the mentorship of Professor John L. Wood. During my graduate studies, I mainly focused on the total syntheses of natural products. In 2024, I joined the Khosla lab and Cui lab as a joint postdoc. Outside the lab, I like cooking, playing basketball, and watching movies
-
Nancy Fang Liu
Clinical Assistant Professor, Medicine
BioNancy Liu is a hospitalist and clinical assistant professor in the Department of Hospital Medicine. She earned her medical degree at the University of Pennsylvania and completed her internal medicine residency training at Stanford Health Care, where she was awarded the Julian Wolfsohn Award for dedication to leadership, clinical practice, and teaching during residency. Her interests are in quality improvement, end of life care, and health equity for underserved populations.
